The relationship between white matter hyperintensity and gait in patients with cerebral small vessel disease - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The association of white matter hyperintensity severity with gait abnormalities in individuals suffering from cerebral small vessel disease

  • By

  • Yajing Wang

  • Zhizhong Zhu

  • Jiaojiao Zhao

  • Shoufeng Liu

  • August 25, 2026

Share

Clinical Report: White Matter Hyperintensity Severity and Gait Abnormalities

Overview

This study evaluates the relationship between white matter hyperintensity (WMH) severity and gait abnormalities in patients with cerebral small vessel disease (CSVD). Findings indicate that moderate-to-severe WMH is associated with slower gait speed and altered kinematic measures.

Background

Cerebral small vessel disease (CSVD) is a common condition that affects older adults and is linked to various clinical manifestations, including gait disorders. White matter hyperintensities (WMH) serve as key neuroimaging markers for CSVD and are associated with increased fall risk and disability.

Data Highlights

Gait ParameterMild WMHModerate-to-Severe WMHStatistical Significance
Gait SpeedFasterSlowerp < 0.05
Stride LengthLongerShorterp < 0.05
Foot-Strike AngleGreaterDiminishedp < 0.05
Toe-Off AngleGreaterDiminishedp < 0.05
Gait SymmetryMore SymmetricIncreased Variabilityp < 0.05

Key Findings

  • Patients with moderate-to-severe WMH showed slower gait speed compared to those with mild WMH.
  • Shorter stride length was observed in the moderate-to-severe WMH group.
  • Diminished foot-strike and toe-off angles were significantly noted in patients with moderate-to-severe WMH.
  • Increased gait-parameter variability was found in the moderate-to-severe WMH group.
  • Toe-off angle and swing-phase coefficient of variation were identified as independent risk factors for gait impairment due to WMH.

Clinical Implications

Clinicians should consider assessing WMH severity in patients with CSVD to better understand their gait abnormalities. Identifying specific gait parameters affected by WMH can aid in early intervention strategies to improve patient mobility and reduce fall risk.

Conclusion

The severity of white matter lesions significantly impacts gait in patients with cerebral small vessel disease.

Related Resources & Content

  1. Frontiers in Neurology, 2026 -- High-dose accelerated intermittent theta burst stimulation targeting the primary motor cortex for gait and cognitive functions in cerebral small vessel disease: a randomized controlled trial
  2. Frontiers in Neurology, 2026 -- Associations of intracranial arterial stenosis and cerebral small vessel diseases with acute ischemic lesions in spontaneous intracerebral hemorrhage
  3. Brain, 2023 -- Alterations in White Matter Associated with Alzheimer's Disease: Are They a Cause, Effect, or Coexisting Condition?
  4. Frontiers in Neurology, 2026 -- Impact of cerebral small vessel disease burden and systemic clinical phenotypes on short-term neurological outcomes after acute ischemic stroke
  5. Neuroimaging standards for research into small vessel disease-advances since 2013 - UCL Discovery
  6. ESO Guideline on covert cerebral small vessel disease | European Stroke Journal | Oxford Academic
  7. Gait and falls in cerebral small vessel disease: a systematic review and meta-analysis - PMC
  8. Association of gait and balance disorders with age-related white matter changes: the LADIS study.
  9. Neuroimaging standards for research into small vessel disease-advances since 2013 - UCL Discovery
  10. ESO Guideline on covert cerebral small vessel disease | European Stroke Journal | Oxford Academic
  11. Gait and falls in cerebral small vessel disease: a systematic review and meta-analysis - PMC
  12. Association of gait and balance disorders with age-related white matter changes: the LADIS study.
  13. Dement Neuropsychol 2025;19:e20250313

Original Source(s)

Related Content